
Pharmalittle: Merck’s Keytruda fails breast cancer trial – STAT STAT
Merck’s Keytruda drug failed to meet the main goal of a late-stage study testing it as a standalone treatment for an aggressive type of breast cancer.

Pharmalittle: Merck’s Keytruda fails breast cancer trial – STAT STAT
Merck’s Keytruda drug failed to meet the main goal of a late-stage study testing it as a standalone treatment for an aggressive type of breast cancer.